174 related articles for article (PubMed ID: 25666946)
21. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
[TBL] [Abstract][Full Text] [Related]
22. Suspension State Promotes Drug Resistance of Breast Tumor Cells by Inducing ABCC3 Overexpression.
Wang Y; Zhang X; Zhao B; Xu Z; Lv Y
Appl Biochem Biotechnol; 2020 Feb; 190(2):410-422. PubMed ID: 31367898
[TBL] [Abstract][Full Text] [Related]
23. Role of the Drug Transporter ABCC3 in Breast Cancer Chemoresistance.
Balaji SA; Udupa N; Chamallamudi MR; Gupta V; Rangarajan A
PLoS One; 2016; 11(5):e0155013. PubMed ID: 27171227
[TBL] [Abstract][Full Text] [Related]
24. [Expression of ABCG2 and p-glycoprotein in residual breast cancer tissue after chemotherapy and their correlation with epithelial-mesenchymal transition].
Qu H; Fang L; Duan L; Long X
Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):236-40. PubMed ID: 24915813
[TBL] [Abstract][Full Text] [Related]
25. STIM1 and STIM2 differently regulate endogenous Ca
Zhang S; Miao Y; Zheng X; Gong Y; Zhang J; Zou F; Cai C
Biochem Biophys Res Commun; 2017 Jun; 488(1):74-80. PubMed ID: 28479254
[TBL] [Abstract][Full Text] [Related]
26. HR+HER2- breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells.
Desai K; Aiyappa R; Prabhu JS; Nair MG; Lawrence PV; Korlimarla A; Ce A; Alexander A; Kaluve RS; Manjunath S; Correa M; Srinath BS; Patil S; Kalamdani A; Prasad M; Sridhar TS
Tumour Biol; 2017 Mar; 39(3):1010428317695028. PubMed ID: 28349782
[TBL] [Abstract][Full Text] [Related]
27. Elevated hepatic multidrug resistance-associated protein 3/ATP-binding cassette subfamily C 3 expression in human obstructive cholestasis is mediated through tumor necrosis factor alpha and c-Jun NH2-terminal kinase/stress-activated protein kinase-signaling pathway.
Chai J; He Y; Cai SY; Jiang Z; Wang H; Li Q; Chen L; Peng Z; He X; Wu X; Xiao T; Wang R; Boyer JL; Chen W
Hepatology; 2012 May; 55(5):1485-94. PubMed ID: 22105759
[TBL] [Abstract][Full Text] [Related]
28. Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control.
Grassi ML; Palma CS; Thomé CH; Lanfredi GP; Poersch A; Faça VM
J Proteomics; 2017 Jan; 151():2-11. PubMed ID: 27394697
[TBL] [Abstract][Full Text] [Related]
29. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG
Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057
[TBL] [Abstract][Full Text] [Related]
30. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD
Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370
[TBL] [Abstract][Full Text] [Related]
31. The Role of TRPC1 in Modulating Cancer Progression.
Elzamzamy OM; Penner R; Hazlehurst LA
Cells; 2020 Feb; 9(2):. PubMed ID: 32046188
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological inhibition of store-operated calcium entry in MDA-MB-468 basal A breast cancer cells: consequences on calcium signalling, cell migration and proliferation.
Azimi I; Bong AH; Poo GXH; Armitage K; Lok D; Roberts-Thomson SJ; Monteith GR
Cell Mol Life Sci; 2018 Dec; 75(24):4525-4537. PubMed ID: 30105615
[TBL] [Abstract][Full Text] [Related]
33. Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells.
Li L; Qi L; Liang Z; Song W; Liu Y; Wang Y; Sun B; Zhang B; Cao W
Int J Mol Med; 2015 Jul; 36(1):113-22. PubMed ID: 26005723
[TBL] [Abstract][Full Text] [Related]
34. Assessment of gene expression of intracellular calcium channels, pumps and exchangers with epidermal growth factor-induced epithelial-mesenchymal transition in a breast cancer cell line.
Davis FM; Parsonage MT; Cabot PJ; Parat MO; Thompson EW; Roberts-Thomson SJ; Monteith GR
Cancer Cell Int; 2013 Jul; 13(1):76. PubMed ID: 23890218
[TBL] [Abstract][Full Text] [Related]
35. miR-143 suppresses epithelial-mesenchymal transition and inhibits tumor growth of breast cancer through down-regulation of ERK5.
Zhai L; Ma C; Li W; Yang S; Liu Z
Mol Carcinog; 2016 Dec; 55(12):1990-2000. PubMed ID: 26618772
[TBL] [Abstract][Full Text] [Related]
36. Functional cyclic AMP response element in the breast cancer resistance protein (BCRP/ABCG2) promoter modulates epidermal growth factor receptor pathway- or androgen withdrawal-mediated BCRP/ABCG2 transcription in human cancer cells.
Xie Y; Nakanishi T; Natarajan K; Safren L; Hamburger AW; Hussain A; Ross DD
Biochim Biophys Acta; 2015 Mar; 1849(3):317-27. PubMed ID: 25615818
[TBL] [Abstract][Full Text] [Related]
37. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
[TBL] [Abstract][Full Text] [Related]
38. Leptin promotes epithelial-mesenchymal transition of breast cancer via the upregulation of pyruvate kinase M2.
Wei L; Li K; Pang X; Guo B; Su M; Huang Y; Wang N; Ji F; Zhong C; Yang J; Zhang Z; Jiang Y; Liu Y; Chen T
J Exp Clin Cancer Res; 2016 Oct; 35(1):166. PubMed ID: 27769315
[TBL] [Abstract][Full Text] [Related]
39. MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer.
Menezes ME; Shen XN; Das SK; Emdad L; Sarkar D; Fisher PB
Oncotarget; 2016 Dec; 7(49):80175-80189. PubMed ID: 27863394
[TBL] [Abstract][Full Text] [Related]
40. Epidermal Growth Factor Potentiates Migration of MDA-MB 231 Breast Cancer Cells by Increasing NaV1.5 Channel Expression.
González-González L; González-Ramírez R; Flores A; Avelino-Cruz JE; Felix R; Monjaraz E
Oncology; 2019; 97(6):373-382. PubMed ID: 31430760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
